On the other hand, the oxidation products produced by COX-2 may have pro-proliferative activity [62], and so the discovered COX-2 induction and 2-AG metabolic transformations should be taken into account during endocannabinoid-based cancer treatment development. This evidence concerns the gene PTGS2 and cancer.